Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to superior efficacy and…
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) — The “Liraglutide and Semaglutide – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Liraglutide and Semaglutide was valued at US$17.1 Billion… [11352 chars]
Source: GlobeNewswire | Published: 2025-12-23T09:13:58Z
Credit: GlobeNewswire
